The total pooled analysis showed a statistically considerable percent decrease in body weight of the retatrutide group when contrasted to the sugar pill group after 36 weeks of treatment, with an overall MD of − 14.33 (95% CI: − 18.27 to − 10.39, P retatrutide cost with insurance</a> in overweight individuals with or without diabetes. Early tests of retatrutide exposed that users might lose approximately a quarter of their body weight in under a year, making it virtually twice as efficient as Ozempic.